Adenia Partners has signed definitive agreements to acquire a majority stake in Parkville Pharmaceuticals, marking Adenia’s first majority investment in Egypt. The stake is being purchased from Admaius Capital Partners, alongside Parkville’s leadership including Dr. Sherif Bassiouny, the company’s chairman, and Dr. Mahmoud Farrag, Parkville’s CEO. The transaction is subject to customary closing conditions and regulatory approvals. Financial terms were not disclosed.
Cairo-headquartered Parkville, founded in 2008, operates across pharmaceuticals, cosmeceuticals, and nutraceuticals, with a portfolio spanning personal care and wellness categories as well as therapeutic pharmaceutical lines. The company develops, manufactures, and distributes products including skincare, haircare, deodorants, food supplements, and select pharmaceutical offerings, and it has built a notable position in Egypt’s growing cosmeceutical market. Parkville operates a production facility in Alexandria and exports to multiple regional markets, with brands that include StarVille, StrongVille, Bobai, Glamy Lan, Shaan, Seropipe, and Sulfax.
Adenia said it plans to support Parkville’s next phase of growth by enhancing the product portfolio, accelerating digital and e-commerce capabilities, and expanding further into regional markets. The investment aligns with Adenia’s stated approach of backing scalable businesses across Africa, leveraging on-the-ground presence and a platform-building strategy focused on sustainable value creation.
On the sell side, Admaius described the past two years as a period of transformation and value creation alongside Parkville’s management team, while Parkville emphasized ambitions to broaden its offerings, strengthen commercial execution, and grow regionally with Adenia as its new partner.
Adenia was advised by Baker McKenzie as legal counsel. Zilla Capital served as sole financial advisor to the existing shareholders, and Matouk Bassiouny acted as legal counsel.
KEY QUOTES
“We are delighted our first acquisition in Egypt is into one of the region’s fastest growing businesses. We see tremendous potential in Parkville’s mission to expand access to affordable, high-quality health and personal care products.”
Stéphane Bacquaert, Managing Partner, Adenia Partners
“We are proud of the solid progress Parkville has achieved over the past two years in partnership with Admaius and our management team. This transformation has delivered a highly positive outcome for Admaius, translating into strong value creation. As we look ahead, we are excited to partner with Adenia to expand our product offering, strengthen our digital and commercial capabilities, and grow regionally. We remain deeply committed to serving our customers with excellence, fostering a healthy and empowering work environment for our people, and delivering sustainable, long-term value for our investors who believe in Parkville’s vision. Our ambition is to position Parkville as a Middle East and Africa champion.”
Dr. Mahmoud Farrag, Co-Founder and CEO of Parkville Pharmaceuticals
“This investment reflects our conviction in Egypt’s long-term fundamentals and in the strength of locally built champions. We look forward to working closely with Parkville’s founders and management team in the next phase of its growth.”
Heba Hakky, Principal, Adenia Partners
